#ShareYourUSStocksWinNvidia

#IntroducingGateStocks
$AMGN ‌A call from a friend in Izmir changed my whole week. He works at a research lab and told me a drug trial had gone better than people hoped. I did not act on the rumor. I opened Gate to look at the chart myself. Amgen was already up at 354.01, a 2.42 percent lift for the day. It had run from a low near 320.96 in late May to a high of 355.08, slicing through its short moving lines with ease. MA5 at 348.82, MA10 at 346.04, and MA30 far down at 335.26 told me buyers had full hold. MACD at 1.67 with DIF over DEA backed that up. That was my cue, not the call. I took a first lot near 348 when it held above the short lines.

US markets have been quiet after the big climb tied to machine learning themes. The S and P 500 and the large tech index move side to side. Cash is not chasing one idea. It is shifting. In the chip field, Nvidia led last year, but much of the hope looks priced in for 2026. I am on hold there and see 110 to 130 as a wait zone. I like AMD more at this level. If it gains share in server chips and lifts output on new nodes, I would build under 140. In energy, oil stays boxed from 70 to 85. Firms tied to sun power and storage look better if rate cuts come. In finance, high rates helped big banks keep firm lending margins. JPMorgan and Bank of America still look solid, while small banks carry risk from property loans, so I pick with care.

For the names I track, Nvidia sits under its 100 day line with weak volume, so I plan to sell rich option value around reports and only add under 115. Tesla moves with talk of self driving cabs and 170 is the base I eye. I like to sell calls when value is high and buy shares if it dips to 150. Apple sees a slower phone cycle, but its services unit helps. I see 185 to 200 as a good band to add for the long run due to cash flow and buyback. AMD looks cheap next to its peer and its data center story lives on. I trade it in a 130 to 145 range and add on a clean break. With Amgen, the lift from 327 to 355 was fast. I will add if it holds a daily close over 355 with volume. My stop sits under 346, right at MA10, because a drop back under that line would tell me the move lost steam.

I have used Gate for years on the crypto side. I was glad to see I could buy US shares there in a few taps. I shift USDT to dollars, pick the share, and place a market order. The chart has the tools I use each day, so it feels like trading coins. Fees are low next to old banks. For now it is only cash trades, no loan use, which helps me keep risk in check.

Coming from crypto, I had to learn three shifts. First, size. A two percent move in Amgen feels large, while ten percent is common in Bitcoin, so I size down. Second, hours. Markets run 9:30 to 16:00 New York time, not all day, so I sleep with less stress. Third, study. In coins, buzz can move price, but with shares I must read income, cash flow, and outlook. For Amgen, its drug pipeline and margin from key drugs are as key to me as token plans are in crypto.

My plan for 2026 is clear. I keep a core in a broad index fund and add high idea names like AMD, Tesla, and Amgen when the chart and story line up. I hold cash near fifteen to twenty percent to use on dips. I do not place big bets before key data. If the Fed hints at cuts, growth and health names should get a lift.

The lesson stays the same. Crypto taught me risk. Shares taught me calm. With apps that link both, the line between them fades. What counts is when you buy, how much you buy, and how you cut loss. This week I eye Amgen holding over 355 and Nvidia holding 120. If both hold, a summer rise may start.